Sera Prognostics (SERA) Change in Accured Expenses (2020 - 2026)
Sera Prognostics' (SERA) quarterly Change in Accured Expenses came in at -$116000.0 in Q1 2026, up 76.42% YoY from -$65751.2 in Q1 2025, and down 115.41% on a QoQ basis from $753000.0 in Q4 2025.
Sera Prognostics (SERA) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Sera Prognostics (SERA) has 7 years of Change in Accured Expenses data on file, last reported at -$116000.0 in Q1 2026.
- Quarterly Change in Accured Expenses rose 76.42% year-over-year to -$116000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 200.47% YoY) and the FY2025 annual result came in at $682000.0, up 218.61% from the prior year.
- Change in Accured Expenses eased to -$116000.0 in Q1 2026, from $753000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $982000.0 in Q3 2022 to a low of -$1.9 million in Q1 2022.
- A 5-year average of -$166117.6 and a median of -$14000.0 in 2024 frame the typical range for Change in Accured Expenses.
- The widest YoY moves for Change in Accured Expenses: up 1520.75% in 2025, down 3414.29% in 2025.
- Tracing SERA's Change in Accured Expenses over 5 years: stood at $20000.0 in 2022, then sank by 1690.0% to -$318000.0 in 2023, then surged by 83.33% to -$53000.0 in 2024, then jumped by 1520.75% to $753000.0 in 2025, then slumped by 115.41% to -$116000.0 in 2026.
- The last three Change in Accured Expenses figures came in at -$116000.0 (Q1 2026), $753000.0 (Q4 2025), and $16000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Sera Prognostics | 103.23 Mn | 103.23 Mn | -20,000.00 | 287,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 287,000.00 |
| Jun 30, 2026 | 287,000.00 |
| Mar 31, 2026 | -116,000.00 |
| Mar 31, 2026 | -116,000.00 |
| Dec 31, 2025 | 753,000.00 |
| Dec 31, 2025 | 753,000.00 |
| Sep 30, 2025 | 16,000.00 |
| Sep 30, 2025 | 16,000.00 |
| Jun 30, 2025 | 405,000.00 |
| Jun 30, 2025 | 405,000.00 |
| Mar 31, 2025 | -492,000.00 |
| Mar 31, 2025 | -492,000.00 |
| Dec 31, 2024 | -53,000.00 |
| Dec 31, 2024 | -53,000.00 |
| Sep 30, 2024 | -666,000.00 |
| Sep 30, 2024 | -666,000.00 |
| Jun 30, 2024 | 158,000.00 |
| Jun 30, 2024 | 158,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Mar 31, 2024 | -14,000.00 |